


. Apixaban 2.5mg .Prevention of venous thromboembolism (VTE) in adult patients who undergo elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF) one or more risk factors such as prior stroke transient ischemic attack (TIA), age ≥ 75 years, hypertension, diabetes mellitus, symptomatic heart failure. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE in adultsActive Ingredient :
Drug Usage Indications:
We empower the fight for health and well being as a human right.
Subscribe for our latest news and updates
For adverse events reporting, please contact us on
PV.Report@evapharma.com